These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6375084

  • 1. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
    Benson RC.
    Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH, Suciu S, Robinson MR, Richards B, Bastable JR, Glashan RW, Bouffioux C, Lardennois B, Williams RE, de Pauw M.
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [Abstract] [Full Text] [Related]

  • 3. Estramustine phosphate in prostate cancer. EORTC experience: preliminary results of Protocol 30762.
    Smith PH, Robinson M, Richards B, Suciu S, De Pauw M, Sylvester R, Denis L.
    Urology; 1984 Jun; 23(6 Suppl):64-8. PubMed ID: 6375083
    [No Abstract] [Full Text] [Related]

  • 4. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC, Cummings K.
    Prog Clin Biol Res; 1989 Jun; 303():177-86. PubMed ID: 2674984
    [No Abstract] [Full Text] [Related]

  • 5. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J.
    Prog Clin Biol Res; 1987 Jun; 243B():229-34. PubMed ID: 3309983
    [No Abstract] [Full Text] [Related]

  • 6. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

  • 7. Cancer of the prostate. Treating metastasis with estramustine phosphate.
    Hoeft RT, Jones AG.
    Am J Nurs; 1982 May; 82(5):829-30. PubMed ID: 6918193
    [No Abstract] [Full Text] [Related]

  • 8. The EORTC Phase III trials in prostatic cancer.
    Robinson MR, Smith PH, Macaluso MP, Sylvester R, de Voogt H.
    Prog Clin Biol Res; 1985 May; 185A():243-9. PubMed ID: 3898132
    [No Abstract] [Full Text] [Related]

  • 9. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP, Slack NH, Mittelman A.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract] [Full Text] [Related]

  • 10. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC, Gill GM, Cummings KB.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
    de Voogt HJ, Smith PH, Pavone-Macaluso M, de Pauw M, Suciu S.
    J Urol; 1986 Feb; 135(2):303-7. PubMed ID: 2935644
    [Abstract] [Full Text] [Related]

  • 12. Estramustine phosphate compared with diethylstilbestrol. A randomized, double-blind, crossover trial for stage D prostate cancer.
    Benson RC, Gill GM.
    Am J Clin Oncol; 1986 Aug; 9(4):341-51. PubMed ID: 3529921
    [Abstract] [Full Text] [Related]

  • 13. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA, Rosenthal H, Mittelman A, Murphy GP.
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [Abstract] [Full Text] [Related]

  • 14. Clinical toxicity and long-term results of Emcyt therapy for prostate cancer.
    Slack NH, Murphy GP.
    Urology; 1984 Jun; 23(6 Suppl):73-7. PubMed ID: 6375085
    [No Abstract] [Full Text] [Related]

  • 15. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug 06; 24(615):74. PubMed ID: 7099111
    [No Abstract] [Full Text] [Related]

  • 16. Change in white cell count during treatment of advanced cancer of the prostate with estramustine phosphate and with stilboestrol.
    Daponte D, Sylvester R, De Pauw M, Fryszman A, Smith RM, Smith PH.
    Br J Urol; 1983 Aug 06; 55(4):408-12. PubMed ID: 6349745
    [Abstract] [Full Text] [Related]

  • 17. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L, Berlin T, Boman J, Collste L, Edsmyr F, Esposti PL, Gustafsson H, Hedlund PO, Hultgren L, Leander G, Nordle O, Norlén H, Tillegård P.
    Scand J Urol Nephrol Suppl; 1980 Aug 06; 55():143-5. PubMed ID: 6259722
    [Abstract] [Full Text] [Related]

  • 18. Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by roswell park memorial institute.
    Murphy GP, Slack NH, Mittelman A.
    Urology; 1984 Jun 06; 23(6 Suppl):54-63. PubMed ID: 6375081
    [No Abstract] [Full Text] [Related]

  • 19. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L, Edsmyr F, Jönsson G, Könyves I.
    Recent Results Cancer Res; 1977 Jun 06; (60):73-7. PubMed ID: 866798
    [Abstract] [Full Text] [Related]

  • 20. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD, O'Donoghue EP, Kennedy CL.
    Br J Urol; 1977 Jun 06; 49(7):717-20. PubMed ID: 339986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.